| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5824144 | Biochemical Pharmacology | 2011 | 8 Pages |
Abstract
Eriodictyol acts as an antagonist of the TRPV1 receptor and as an antioxidant; it induces antinociception without some of the side effects and limitations such as hyperthermia that are expected for TRPV1 antagonists.
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology
Authors
Mateus Fortes Rossato, Gabriela Trevisan, Cristiani Isabel Banderó Walker, Jonatas Zeni Klafke, Ana Paula de Oliveira, Jardel Gomes Villarinho, Ricardo Basso Zanon, Luiz Fernando Freire Royes, Margareth Linde Athayde, Marcus Vinicius Gomez,